Is CalciMedica, Common Stock a Good Investment?

CalciMedica, Common Investment Advice

  CALC
To provide specific investment advice or recommendations on CalciMedica, Common Stock stock, we recommend investors consider the following general factors when evaluating CalciMedica, Common Stock. This will help you to make an informed decision on whether to include CalciMedica, Common in one of your diversified portfolios:
  • Examine CalciMedica, Common's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
  • Research CalciMedica, Common's leadership team and their track record. Good management can help CalciMedica, Common navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
  • Consider the overall health of the Biotechnology space and any emerging trends that could impact CalciMedica, Common's business and its evolving consumer preferences.
  • Compare CalciMedica, Common's performance and market position to its competitors. Analyze how CalciMedica, Common is positioned in terms of product offerings, innovation, and market share.
  • Check if CalciMedica, Common pays a dividend and its dividend yield and payout ratio.
  • Review what financial analysts are saying about CalciMedica, Common's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in CalciMedica, Common Stock stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if CalciMedica, Common Stock is a good investment.
 
Sell
 
Buy
Strong Sell
We provide trade advice to complement the prevailing expert consensus on CalciMedica, Common Stock. Our dynamic recommendation engine uses a multidimensional algorithm to analyze the company's potential to grow using all technical and fundamental data available at the time. To make sure CalciMedica, Common is not overpriced, please confirm all CalciMedica, Common Stock fundamentals, including its price to book, short ratio, retained earnings, as well as the relationship between the total debt and number of employees . Given that CalciMedica, Common Stock has a shares owned by institutions of 43.86 %, we suggest you to validate CalciMedica, Common Stock market performance and probability of bankruptcy to ensure the company can sustain itself in the current economic cycle given your prevailing risk tolerance and investing horizon.

Market Performance

Very WeakDetails

Volatility

Relatively riskyDetails

Hype Condition

Under hypedDetails

Current Valuation

UndervaluedDetails

Odds Of Distress

Very HighDetails

Economic Sensitivity

Moves totally opposite to the marketDetails

Investor Sentiment

ImpartialDetails

Analyst Consensus

Strong BuyDetails

Financial Strenth (F Score)

FrailDetails

Financial Leverage

InapplicableDetails

Reporting Quality (M-Score)

Unlikely ManipulatorDetails

Examine CalciMedica, Common Stock

Researching CalciMedica, Common's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 17.0% of the company shares are held by company insiders. The book value of CalciMedica, Common was currently reported as 1.42. The company recorded a loss per share of 1.11. CalciMedica, Common Stock had not issued any dividends in recent years. The entity had 1:14 split on the 20th of March 2023.
To determine if CalciMedica, Common is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding CalciMedica, Common's research are outlined below:
CalciMedica, Common generated a negative expected return over the last 90 days
CalciMedica, Common has high historical volatility and very poor performance
CalciMedica, Common has a very high chance of going through financial distress in the upcoming years
Net Loss for the year was (34.36 M) with profit before overhead, payroll, taxes, and interest of 0.
CalciMedica, Common generates negative cash flow from operations
CalciMedica, Common has a frail financial position based on the latest SEC disclosures
About 17.0% of the company shares are held by company insiders
Latest headline from thelincolnianonline.com: CalciMedica, Inc. Sees Significant Growth in Short Interest

CalciMedica, Common Quarterly Accounts Payable

1.54 Million

CalciMedica, Common uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in CalciMedica, Common Stock. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to CalciMedica, Common's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
8th of February 2024
Upcoming Quarterly Report
View
10th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
8th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View
Earnings surprises can significantly impact CalciMedica, Common's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises CalciMedica, Common's investors have experienced.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2024-08-08
2024-06-30-0.53-0.360.1732 
2023-11-09
2023-09-30-1.14-0.820.3228 
2022-03-10
2021-12-31-5.12-5.74-0.6212 
2024-03-28
2023-12-31-0.87-0.230.6473 
2024-05-13
2024-03-31-0.670.010.68101 
2021-03-04
2020-12-31-0.4-1.38-0.98245 
2022-05-10
2022-03-31-5.35-6.72-1.3725 
2021-05-12
2021-03-31-6.16-7.56-1.422 

CalciMedica, Common's market capitalization trends

The company currently falls under 'Micro-Cap' category with a current market capitalization of 43.41 M.

Market Cap

5.06 Million

CalciMedica, Common's profitablity analysis

Last ReportedProjected for Next Year
Return On Tangible Assets(3.24)(3.08)
Return On Capital Employed(3.08)(2.93)
Return On Assets(3.24)(3.08)
Return On Equity(4.84)(4.60)
Determining CalciMedica, Common's profitability involves analyzing its financial statements and using various financial metrics to determine if CalciMedica, Common is a good buy. For example, gross profit margin measures CalciMedica, Common's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of CalciMedica, Common's profitability and make more informed investment decisions.
Please note, the presentation of CalciMedica, Common's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, CalciMedica, Common's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of CalciMedica, Common's management manipulating its earnings.

Basic technical analysis of CalciMedica, Stock

As of the 4th of January, CalciMedica, Common shows the Standard Deviation of 5.41, mean deviation of 3.15, and Risk Adjusted Performance of (0.03). CalciMedica, Common Stock technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.

CalciMedica, Common's insider trading activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific CalciMedica, Common insiders, such as employees or executives, is commonly permitted as long as it does not rely on CalciMedica, Common's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases CalciMedica, Common insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Middleton Fred A over three weeks ago
Acquisition by Middleton Fred A of 4800 shares of CalciMedica, Common at 2.65 subject to Rule 16b-3
 
Middleton Fred A over two months ago
Acquisition by Middleton Fred A of 13184 shares of CalciMedica, Common at 3.702 subject to Rule 16b-3
 
Eric Roberts over three months ago
Acquisition by Eric Roberts of 45543 shares of CalciMedica, Common at 5.36 subject to Rule 16b-3
 
Dunn Michael J. over three months ago
Disposition of 11761 shares by Dunn Michael J. of CalciMedica, Common at 1. subject to Rule 16b-3
 
Shaw Allan over three months ago
Acquisition by Shaw Allan of 10000 shares of CalciMedica, Common at 4.16 subject to Rule 16b-3
 
Guerard Frederic over three months ago
Acquisition by Guerard Frederic of 10000 shares of CalciMedica, Common at 4.16 subject to Rule 16b-3
 
Wilson Robert N over three months ago
Acquisition by Wilson Robert N of 54000 shares of CalciMedica, Common at 3.719 subject to Rule 16b-3
 
Eric Roberts over three months ago
Acquisition by Eric Roberts of 5000 shares of CalciMedica, Common at 4.04 subject to Rule 16b-3
 
Wilson Robert N over six months ago
Acquisition by Wilson Robert N of 51278 shares of CalciMedica Common at 3.52 subject to Rule 16b-3
 
Geffken Daniel E. over six months ago
Acquisition by Geffken Daniel E. of 10000 shares of CalciMedica Common at 5.45 subject to Rule 16b-3
 
Eric Roberts over six months ago
Acquisition by Eric Roberts of 77500 shares of CalciMedica Common at 4.16 subject to Rule 16b-3
 
Eric Roberts over six months ago
Acquisition by Eric Roberts of 3254 shares of CalciMedica Common at 3.9 subject to Rule 16b-3

Understand CalciMedica, Common's technical and predictive indicators

Using predictive indicators to make investment decisions involves analyzing CalciMedica, Common's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.

Consider CalciMedica, Common's intraday indicators

CalciMedica, Common intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of CalciMedica, Common stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

CalciMedica, Common Corporate Filings

20th of December 2024
Other Reports
ViewVerify
13th of December 2024
Other Reports
ViewVerify
F4
6th of December 2024
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
F3
26th of November 2024
The schedule filed by any person or group who acquires beneficial ownership of more than 5% of a voting class of a company's equity securities registered under Section 12 of the Act
ViewVerify
CalciMedica, Common time-series forecasting models is one of many CalciMedica, Common's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary CalciMedica, Common's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

CalciMedica, Stock media impact

Far too much social signal, news, headlines, and media speculation about CalciMedica, Common that are available to investors today. That information is available publicly through CalciMedica, media outlets and privately through word of mouth or via CalciMedica, internal channels. However, regardless of the origin, that massive amount of CalciMedica, data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of CalciMedica, Common news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of CalciMedica, Common relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to CalciMedica, Common's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive CalciMedica, Common alpha.

CalciMedica, Common Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards CalciMedica, Common can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

CalciMedica, Common Corporate Executives

Elected by the shareholders, the CalciMedica, Common's board of directors comprises two types of representatives: CalciMedica, Common inside directors who are chosen from within the company, and outside directors, selected externally and held independent of CalciMedica,. The board's role is to monitor CalciMedica, Common's management team and ensure that shareholders' interests are well served. CalciMedica, Common's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, CalciMedica, Common's outside directors are responsible for providing unbiased perspectives on the board's policies.
Kenneth StaudermanCoFounder OfficerProfile
Stefan MDCoFounder AdvisorProfile
Patrick HoganCoFounder AdvisorProfile
Anjana RaoCoFounder AdvisorProfile
When determining whether CalciMedica, Common Stock offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of CalciMedica, Common's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Calcimedica, Common Stock Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Calcimedica, Common Stock Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CalciMedica, Common Stock. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CalciMedica, Common. If investors know CalciMedica, will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CalciMedica, Common listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.11)
Return On Assets
(0.65)
Return On Equity
(0.84)
The market value of CalciMedica, Common Stock is measured differently than its book value, which is the value of CalciMedica, that is recorded on the company's balance sheet. Investors also form their own opinion of CalciMedica, Common's value that differs from its market value or its book value, called intrinsic value, which is CalciMedica, Common's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CalciMedica, Common's market value can be influenced by many factors that don't directly affect CalciMedica, Common's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
In summary, please note that there is a difference between CalciMedica, Common's value and its price, as these two are different measures arrived at by various means. Investors typically determine if CalciMedica, Common is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CalciMedica, Common's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.